Over-the-counter drug · BLA
Novolin 70/30 (Human insulin) NDC 0169-1837
Insulin human 100 [iU]/mL · Injection, Suspension · Subcutaneous · Novo Nordisk Pharmaceutical Industries, LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0169-1837-02 | 0016918370200169183702 | 1 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIALMarketed from Jun 25, 1991 | |
| 0169-1837-11 | 0016918371100169183711 | 1 VIAL in 1 CARTON (0169-1837-11) / 10 mL in 1 VIALMarketed from Jun 25, 1991 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Novolin 70/30Suffix: 70/30
- Generic name (nonproprietary)
- human insulin
- Active ingredients
- Insulin human — 100 [iU]/mL
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Labeler
- Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169
- Product type
- Over-the-counter drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 019991
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 0169-1837_bea778f8-a1f8-4e14-a25f-34de42289671SPL ID bea778f8-a1f8-4e14-a25f-34de42289671
- Pharmacologic class
- Insulin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400169183702followed by a unit qualifier and the quantityPackage 00169-1837-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0169-1837
- What is NDC 0169-1837?
- 0169-1837 is the product NDC for Novolin 70/30 (human insulin), Insulin human 100 [iU]/mL injection, suspension, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Novolin 70/30 (Human Insulin).
- What is the active ingredient?
- Insulin human.
- Who is the labeler?
- Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Novolin 70/30?
- 2 other product NDCs are listed under this name. See all Novolin 70/30 NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Novolin 70/30 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3007 | 00169-3007-1500169-3007-25 |
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-0403 | 50090-0403-00 |
Other NDCs under BLA 019991
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3007 |
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-0403 |